Radiographic progression in rheumatoid arthritis: Does it reflect outcome? Does it reflect treatment?

le van der Heijde, D
Foilsithe 2001

Follow up studies in rheumatoid arthritis

le Landewe, R, van der Heijde, D
Foilsithe 2002

Imaging: do erosions heal?

le van der Heijde, D, Landewe, R
Foilsithe 2003

Presentation and analysis of radiographic data in clinical trials and observational studies

le Landewe, R, van der Heijde, D
Foilsithe 2005

Optimal dosage and route of administration of methotrexate in rheumatoid arthritis: a systematic review of the literature

le Visser, K, van der Heijde, D
Foilsithe 2008

Long-term safety of methotrexate monotherapy in patients with rheumatoid arthritis: a systematic literature research

le Salliot, C, van der Heijde, D
Foilsithe 2008

Definition of discontinuation of anti-tumour necrosis factor therapy in rheumatoid arthritis: a preliminary proposal

le Braun, J, Sieper, J, van der Heijde, D
Foilsithe 2003

Using estimated yearly progression rates to compare radiographic data across recent randomised controlled trials in rheumatoid arthritis

le Strand, V, Landewe, R, van der Heijde, D
Foilsithe 2002

ICF based comparison of disease specific instruments measuring physical functional ability in ankylosing spondylitis

le Sigl, T, Cieza, A, van der Heijde, D, Stucki, G
Foilsithe 2005

Psoriatic arthritis imaging: a review of scoring methods

le van der Heijde, D, Sharp, J, Wassenberg, S, Gladman, D
Foilsithe 2005

Subtle changes in individual joints result in both positive and negative change scores in a patient: results from a clinical trial in patients with rheumatoid arthritis

le Lukas, C, Landewé, R, Fatenejad, S, van der Heijde, D
Foilsithe 2008

How the type of risk reduction influences required sample sizes in randomised clinical trials

le Bruynesteyn, K, Wanders, A, Landewe, R, van der Heijde, D
Foilsithe 2004

Seronegative spondyloarthropathies: to lump or split?

le Nash, P, Mease, P, Braun, J, van der Heijde, D
Foilsithe 2005

Current evidence for the management of ankylosing spondylitis: a systematic literature review for the ASAS/EULAR management recommendations in ankylosing spondylitis

le Zochling, J, van der Heijde, D, Dougados, M, Braun, J
Foilsithe 2006

The process of producing recommendations for rheumatic diseases: what is evidence?

le Zochling, J, van der Heijde, D, Dougados, M, Braun, J
Foilsithe 2006

Ankylosing spondylitis: evidence for a non-HLA-B*27 protective effect

le VAN DER LINDEN, S., VAN DER HEIJDE;, D., BROWN, M., WORDSWORTH, P.
Foilsithe 1998

Radiography as primary outcome in rheumatoid arthritis: acceptable sample sizes for trials with 3 months' follow up

le Bruynesteyn, K, Landewe, R, van der Linden, S., van der Heijde, D
Foilsithe 2004

Which patients with ankylosing spondylitis should be treated with tumour necrosis factor inhibiting therapy? A survey among Dutch rheumatologists

le Landewe, R, Rump, B, van der Heijde, D, van der Linden, S
Foilsithe 2004

Treatment trials in ankylosing spondylitis: current and future considerations

le van der Heijde, D, Braun, J, McGonagle, D, Siegel, J
Foilsithe 2002

Twenty‐eight‐joint counts invalidate the DAS28 remission definition owing to the omission of the lower extremity joints: a comparison with the original DAS remission

le Landewé, R, van der Heijde, D, van der Linden, S, Boers, M
Foilsithe 2006